$3.94
▲ +1.6% Today
as of Jul 22, 16:51 ET
Last 30 days
Recent Press Releases & News
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View
Overview
52-week range
$2.56
$16
10% of range
Avg surprise (last 3)
-39.3%
Avg reaction (last 2)
+2.8%
100% positive
Latest IV / EM
96%
EM ±22.0% · $4 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $-0.20 | $-0.14 | -42.9% | -2,100% | +2.7% | earnings |
| Tue Aug 5, 2025 | Jun/2025 | $-0.06 | $-0.02 | -200.0% | — | — | earnings |
| Tue May 6, 2025 | Mar/2025 | $0.01 | $-0.04 | +125.0% | — | +2.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.13 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 4, 2026 | Jun/2026 | OTHER | -$0.20 | -$0.06 | -233.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $6M | — | $7M | $7M | $8M | — | $5M | $5M |
| Gross profit | $44M | — | $53M | $55M | $43M | — | $48M | $46M |
| Operating income | $-9M | — | $-2M | $-451,562 | $-1M | — | $-4M | $-6M |
| Net income | $-9M | — | $-4M | $-2M | $-183,778 | — | $-5M | $-7M |
| EPS (diluted) | $-0.20 | — | — | $-0.05 | $-0.02 | — | $-0.13 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | $36M | $34M | $35M | $38M | $36M |
| Inventory | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M |
| Total current assets | $52M | $52M | $41M | $49M | $50M | $52M | $49M | $45M |
| Total assets | $70M | $70M | $66M | $74M | $74M | $76M | $73M | $64M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $55M | $47M | $63M | $73M | $74M | $84M | $79M | $66M |
| Total equity | $15M | $23M | $1M | $-2M | $-2M | $-9M | $-8M | $-4M |